Latest filing published 07 Aug 2020 for Neuronetics, Inc..
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Brian E. Farley has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Entellus Medical Inc and Neuronetics, Inc. The record holds 40 filings, for trades running from 30 August 2016 to 5 August 2020.
On the open market, the record shows 4 purchases worth €223k and 25 sales worth €5.3M. On balance, insiders were net sellers of €5.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 6 share grants. 2020 to date brings 2 purchases and no sales.
In size, the median ticket on the buying side is €61k. 2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. After 4 purchases with a full 90-day history, the hit rate stands at 50% and the median 90-day move at -6.3%. This is a record of the past, not a forecast.
On 7 August 2020 came the latest disclosure, a share grant in Neuronetics, Inc. The clock since the last published purchase (16 March 2020) now reads 2,412 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 40 declarations